2022
DOI: 10.36660/abc.20220179
|View full text |Cite
|
Sign up to set email alerts
|

Posicionamento sobre Segurança Cardiovascular das Vacinas contra COVID-19 - 2022

Abstract: Posicionamento sobre Segurança Cardiovascular das Vacinas contra COVID-19 -2022O relatório abaixo lista as declarações de interesse conforme relatadas à SBC pelos especialistas durante o período de desenvolvimento deste posicionamento, 2022. Especialista Tipo de relacionamento com a indústriaBruno Pereira Valdigem Nada a ser declarado Carisi Anne PolanczykDeclaração financeira A -Pagamento de qualquer espécie e desde que economicamente apreciáveis, feitos a (i) você, (ii) ao seu cônjuge/ companheiro ou a qualq… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…For additional context, data suggest that one million second mRNA COVID-19 vaccine doses could prevent 11000 cases, 560 hospitalizations, 138 ICU admissions, and six deaths among 12-29-year-olds, compared with 39-47 potential cases of vaccine-related myocarditis. 194 Vaccine-related myocarditis also tends to be milder when compared with COVID-19-related cases, which have been associated with a greater risk of hospitalization and death. 193 …”
Section: Discussionmentioning
confidence: 99%
“…For additional context, data suggest that one million second mRNA COVID-19 vaccine doses could prevent 11000 cases, 560 hospitalizations, 138 ICU admissions, and six deaths among 12-29-year-olds, compared with 39-47 potential cases of vaccine-related myocarditis. 194 Vaccine-related myocarditis also tends to be milder when compared with COVID-19-related cases, which have been associated with a greater risk of hospitalization and death. 193 …”
Section: Discussionmentioning
confidence: 99%